Favipiravir-resistant influenza A virus shows potential for transmission
Favipiravir-resistant influenza A virus shows potential for transmission
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Favipiravir is a nucleoside analogue which has been licensed to treat influenza in the event of a new pandemic. We previously described a favipiravir resistant influenza A virus generated by in vitro passage in presence of drug with two mutations: K229R in PB1, which conferred resistance at a cost to polymerase activity, and P653L in PA, which comp...
Alternative Titles
Full title
Favipiravir-resistant influenza A virus shows potential for transmission
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2552289764
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2552289764
Other Identifiers
ISSN
1553-7374,1553-7366
E-ISSN
1553-7374
DOI
10.1371/journal.ppat.1008937
